1.科研項目 (1)山西省科技創(chuàng)新計劃創(chuàng)新平臺項目,2022P004,,腫瘤免疫與靶向藥物研發(fā)實驗室,,10萬,,2022.10-2025.10,在研,,負責人 (2)中央引導地方科技發(fā)展基金,,YDZJSX2022A057,40萬,,2022.4-2025.4,,主持,在研 2.學術論文 (1)CXCL8 induces M2 macrophages polarization and inhibits CD8+ T cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer. FASEB J, 2023, published on line (通訊作者, 2區(qū)) (2) RNA demethylase ALKBH5 suppresses tumorigenesis via inhibitingproliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer. Translational Oncology, 2023, published on line (通訊作者, 3區(qū)) (3)miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8+ T cell-mediated immune attack in colorectal cancer. FASEB J, 2021, 35(8):e21776 (通訊作者, 2區(qū)) 3.學術榮譽:山西省優(yōu)秀青年學術帶頭人 4.科技獎勵:山西省科技進步獎二等獎,,2023.11 5.發(fā)明專利:無 6.學術任職:山西省生物化學與分子生物學會常務理事 |